Literature DB >> 24320684

Which patients are not suitable for a subcutaneous ICD: incidence and predictors of failed QRS-T-wave morphology screening.

Louise R A Olde Nordkamp1, Joppe L F Warnaars1, Kirsten M Kooiman1, Joris R de Groot1, Boudewijn R A M Rosenmöller1, Arthur A M Wilde1, Reinoud E Knops1.   

Abstract

BACKGROUND: The subcutaneous cardioverter-defibrillator (S-ICD) relies on a pre-implantation QRS-T morphology screening (TMS) of the ECG to assure that it reliably detects the QRS complexes and T waves. The prevalence and clinical characteristics of the patients who fail this TMS is unknown. METHODS AND
RESULTS: QRS-TMS was done in 230 consecutive ICD outpatients (75% male, age 57 ± 15 years) without an indication for cardiac pacing, using an ECG simulating the 3 sensing vectors of the S-ICD (TMS-ECG). Patients were defined suitable when at least 1 sensing vector was considered appropriate in both supine and standing position. In total, 7.4% of patients, who were all male, were considered not suitable for a S-ICD according to the TMS-ECG. Independent predictors for TMS failure were hypertrophic cardiomyopathy (HCM; odds ratio [OR] 12.6), a heavy weight (OR 1.5), a prolonged QRS duration (OR 1.5) and a R:T ratio <3 in the lead with the largest T wave on a standard 12-lead surface ECG (OR 14.6).
CONCLUSION: In patients without an indication for pacing, 7.4% would have been not suitable for a S-ICD according to the TMS. HCM, a heavy weight, a prolonged QRS duration and a R:T ratio <3 in the ECG lead with the largest T wave were independently associated with TMS failure. These data might alert physicians that selection of patients for a S-ICD should be considered with special caution in certain patient groups, because they may not satisfy ECG criteria for adequate sensing.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  ICD sensing; implantable cardioverter defibrillator; subcutaneous ICD; sudden cardiac death; ventricular tachycardia

Mesh:

Year:  2014        PMID: 24320684     DOI: 10.1111/jce.12343

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  27 in total

Review 1.  Initial experience of subcutaneous implantable cardioverter defibrillators in Singapore: a case series and review of the literature.

Authors:  Tien Siang Eric Lim; Boon Yew Tan; Kah Leng Ho; Chuh Yih Paul Lim; Wee Siong Teo; Chi-Keong Ching
Journal:  Singapore Med J       Date:  2015-10       Impact factor: 1.858

Review 2.  Subcutaneous implantable cardiac defibrillators: indications and limitations.

Authors:  Maria Grazia Bongiorni; Stefano Viani; Giulio Zucchelli; Andrea Di Cori; Luca Segreti; Luca Paperini; Dianora Levorato; Adriano Boem; Giulia Branchitta; Diana Andreini; Ezio Soldati
Journal:  Curr Heart Fail Rep       Date:  2015-02

Review 3.  The subcutaneous ICD-current evidence and challenges.

Authors:  Kiran Haresh Kumar Patel; Pier D Lambiase
Journal:  Cardiovasc Diagn Ther       Date:  2014-12

4.  Conventional and right-sided screening for subcutaneous ICD in a population with congenital heart disease at high risk of sudden cardiac death.

Authors:  Pau Alonso; Joaquín Osca; Joaquín Rueda; Oscar Cano; Pedro Pimenta; Ana Andres; María José Sancho; Luis Martinez
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-05-15       Impact factor: 1.468

5.  Prevalence of subcutaneous implantable cardioverter-defibrillator based on template ECG screening and ineligible surface ECG predicting factors in patients with hypertrophic cardiomyopathy in China.

Authors:  Lanyan Guo; Minxia Zhang; Miaoyang Hu; Bo Wang; Jing Wang; Lei Zuo; Weiping Yang; Bing Liu; Liwen Liu
Journal:  Heart Vessels       Date:  2018-11-21       Impact factor: 2.037

6.  Subcutaneous implantable cardioverter defibrillator eligibility according to a novel automated screening tool and agreement with the standard manual electrocardiographic morphology tool.

Authors:  Pietro Francia; Matteo Ziacchi; Paolo De Filippo; Stefano Viani; Antonio D'Onofrio; Vincenzo Russo; Carmen Adduci; Mauro Biffi; Paola Ferrari; Valter Bianchi; Ernesto Ammendola; Francesca Palano; Jessica Frisoni; Sergio Valsecchi; Mariolina Lovecchio; Maria Grazia Bongiorni
Journal:  J Interv Card Electrophysiol       Date:  2018-03-03       Impact factor: 1.900

7.  Analysis of Screening Electrocardiogram for the Subcutaneous Defibrillator in Adults with Congenital Heart Disease.

Authors:  Vincent C Thomas; Mark Peterson; Martin McDaniel; Humberto Restrepo; Abraham Rothman; Amit Jain
Journal:  Pediatr Cardiol       Date:  2017-05-22       Impact factor: 1.655

8.  Dialytic interval and the timing of electrocardiographic screening for subcutaneous cardioverter-defibrillator placement in chronic hemodialysis patients.

Authors:  Cindy You; Shishir Sharma; Aakash Bavishi; Christopher A Groh; Yazan Alia; Basil Saour; Rod Passman
Journal:  J Interv Card Electrophysiol       Date:  2018-03-10       Impact factor: 1.900

9.  The Emerging Roles of Leadless Devices.

Authors:  Jeffrey Arkles; Joshua Cooper
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-02

10.  The utility of routine clinical 12-lead ECG in assessing eligibility for subcutaneous implantable cardioverter defibrillator.

Authors:  Jason A Thomas; Erick Andres Perez-Alday; Christopher Hamilton; Muammar M Kabir; Eugene A Park; Larisa G Tereshchenko
Journal:  Comput Biol Med       Date:  2018-05-08       Impact factor: 4.589

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.